Limpia Pecho

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Limpia Pecho
Generic name: DEXTROMETHORPHAN HBR, GUAIFENESIN
Manufacturer: Llorens Pharmaceutical International Division, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: cbaea3e4-4c4b-4ff9-ae6f-95b6a2d3faf3
SPL ID: 47467f14-6d34-afd0-e063-6294a90a0f26
Version: 7
Effective date: 2025-12-31
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:43:14

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		Limpia Pecho	openfda.brand_name
generic name		DEXTROMETHORPHAN HBR, GUAIFENESIN	openfda.generic_name
manufacturer name		Llorens Pharmaceutical International Division, Inc.	openfda.manufacturer_name
ndc	package	54859-011-04	openfda.package_ndc
ndc	product	54859-011	openfda.product_ndc
ndc11	package	54859001104	derived:openfda.package_ndc
rxcui		996520	openfda.rxcui
spl id		47467f14-6d34-afd0-e063-6294a90a0f26	id
spl set id		cbaea3e4-4c4b-4ff9-ae6f-95b6a2d3faf3	set_id
unii		9D2RTI9KYH	openfda.unii
unii		495W7451VQ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not exceed recommended dosage Do not use if you are now taking a monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease) or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this prduct. Ask a doctor before use if you have a cough that is accompanied by excessive phlegm (mucus) a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema. Stop use and ask a dotor if cough persist for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache. These may be signs of a serious condition

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.